Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_provenance.
- NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_assertion description "[The US Food and Drug Administration-approved BRAF inhibitors, vemurafenib and dabrafenib, have demonstrated superior efficacy in patients with BRAF-mutant melanomas but have limited efficacy in BRAF-mutant colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_provenance.
- NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_assertion evidence source_evidence_literature NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_provenance.
- NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_assertion SIO_000772 25467940 NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_provenance.
- NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_assertion wasDerivedFrom befree-2016 NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_provenance.
- NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_assertion wasGeneratedBy ECO_0000203 NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_provenance.
- befree-2016 importedOn "2016-02-19" NP1244197.RABc_AJ4kFXMTD7S9XxDBylAkLTDAPljYThiDkdiM53gg130_provenance.